Pharmaceutical services company Open Orphan is hatching a plan to make Covid-19 antibody tests available to employers in Ireland. Open Orphan subsidiary hVivo has partnered with Swiss pharma group Quotient ...

Open Orphan Plc (LON:ORPH), a rapidly growing specialist pharmaceutical services company which has a focus on orphan drugs and is the world leader in the testing of vaccines and antivirals using human challenge ...

Our over-reliance on antibiotics to find relief from numerous ailments, including cold and flu symptoms, is a major health concern – according to the Centers for Disease Control and Prevention. ...

Open Orphan plc (LON:ORPH) the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is the world leader in the testing of vaccines and ...

With more than four million cases and just under 300,000 deaths to date, the pressure created by the coronavirus pandemic is enormous. But Irish companies are coming out in force ...

The number of individuals who want to be infected as part of vaccine development continues to grow despite coronavirus emerging as the most fatal contagious disease. A global advocacy group ...

Open Orphan plc (LON:ORPH) the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is the world leader in the testing of vaccines and ...

Open Orphan's Cathal Friel discusses their new major contract win with a US biotechnology company, pipeline of contracts, cost cutting & profitability and the progress of their universal flu vaccine in this exclusive interview with DirectorsTalk.

A Year of seasons in the Life of an Asthmatic: Asthma sufferers will often find certain triggers such as pollen, dust, animal fur and pollution can cause an increase in ...

Open Orphan plc (LON:ORPH) Chairman Cathal Friel joins DirectorsTalk to discuss the signing of a new contract with a US biotechnology Company for the provision of a respiratory syncytial virus (RSV) ...